The Government has introduced strategic reforms to streamline cancer treatment by eliminating repeated Social Health Authority (SHA) pre-authorisation, allowing patients to access multiple treatment cycles under a single approval and use unified health records across contracted hospitals.
The reforms are expected to ease access to healthcare for 54,465 cancer patients currently receiving treatment under SHA by reducing administrative bottlenecks, lengthy hospital queues, treatment delays and the financial burden associated with cancer care.
Cabinet Secretary (CS) for Health, Aden Duale, said the changes were informed by longstanding concerns raised by cancer patients and healthcare providers over repeated pre-authorisation, fragmented care across hospitals and bureaucratic hurdles that have disrupted access to essential services.
Kenya records approximately 35,867 new cancer cases and 22,888 cancer-related deaths annually, underscoring the need to strengthen access to timely and affordable treatment.
“Our goal is simple: less bureaucracy, better quality of care and greater financial protection for cancer patients,” said CS Duale, when he officially opened the 9th Kenya International Cancer Conference in Mombasa.
The Conference was organised by the Kenya Society of Haematology and Oncology (KESHO) in partnership with the Ministry of Health.
The CS said the Ministry, through the Office of the Director-General for Health, had developed the National Cancer Control Protocol (NCCP), which is being implemented digitally through the Digital Health Agency’s SHA Oncology Module.
Under the new arrangement, pre-authorisation will be patient-based rather than facility-based, meaning patients will no longer require repeated approvals for every treatment cycle covered under their authorised care plans.
“Cancer patients already registered and approved by SHA will no longer need repeated pre-authorisation for every treatment cycle covered by their approved care plan. One approval can cover multiple cycles, investigations and supportive medication, where applicable,” said Duale.
He explained that patients would be able to access their approved treatment at any SHA-contracted hospital, providing greater flexibility to seek care across facilities while reducing paperwork, queues and unnecessary delays.
The reforms will also ensure that every cancer patient has a unified oncology record accessible across participating healthcare facilities, eliminating duplicate records and fragmented medical information.
According to the CS, the integrated records will improve coordination among healthcare providers and ensure continuity of treatment regardless of where patients seek medical attention.
CS Duale urged oncologists to uphold professional standards and ensure patients receive quality care through proper treatment planning, specialist supervision and appropriate medication.
“Oncologists must lead treatment planning, prescribe appropriate chemotherapy regimens and ensure correct patient-specific dosing,” he said.
He further called for prudent management of the Sh800,000 oncology benefit under SHA, clarifying that the government had not reduced the allocation, but was seeking to improve its utilisation.
“We must stop unnecessary consumption of a patient’s allocation by hospitals, only for patients to be asked to make additional out-of-pocket payments before exhausting their benefit,” stated the CS.
The government increased the oncology benefit from Sh550,000 to Sh800,000 effective December 1, 2025, in a move aimed at strengthening financial protection for cancer patients.
CS Duale disclosed that SHA had paid healthcare facilities more than Sh11.6 billion in oncology claims, out of Sh194.8 billion disbursed for all healthcare services.
“Our undertaking is that illness, including cancer, must never again become a sentence to poverty,” affirmed the CS.
The government is also expanding access to specialised cancer treatment through decentralisation of services and investments in regional healthcare infrastructure.
Currently, the country has six comprehensive cancer centres at the Kenyatta National Hospital, Kenyatta University Teaching, Referral and Research Hospital, Moi Teaching and Referral Hospital, as well as regional centres in Nakuru, Garissa and Mombasa.
Cancer treatment services are also being expanded, with Kisii and Jaramogi Oginga Odinga Teaching and Referral Hospital expected to come on stream. Additionally, 13 counties are currently running oncology programmes.
On access to affordable medicines, Duale said the government had signed an access agreement with pharmaceutical firm Pfizer, resulting in price reductions of between 70 and 90 per cent for nine innovative cancer medicines.
A separate partnership with Roche has reduced the cost of Herceptin, a breast cancer drug, from Sh120,000 to Sh40,000 per treatment session for eligible patients under SHA.
To address operational challenges affecting service delivery, the CS directed SHA, the Digital Health Agency and Ministry of Health officials to hold a consultative meeting with KESHO leadership next week.
He said the meeting would seek to resolve emerging challenges in the implementation of the oncology package, with a report expected on his desk by Thursday.
KESHO President, Dr Gladwell Kiarie, welcomed the government’s increased attention to cancer care, citing the expansion of the oncology benefit, investment in regional treatment infrastructure, decentralisation of specialised services and the broader commitment to strengthening Universal Health Coverage.
However, she cautioned that policy commitments must translate into tangible improvements in patients’ experiences, noting that operational challenges within the SHA platform continued to affect healthcare delivery.
“As clinicians, we are increasingly concerned about the operational challenges being experienced within the SHA platform. We recognise that major health financing reforms require adjustments, systems strengthening and continuous improvement. We also appreciate the need for standardisation, accountability and prudent utilisation of public resources,” said Dr Kiarie.
She emphasised that timely access to cancer treatment was critical, warning that administrative delays, could have serious consequences for patients.
“However, cancer is a disease in which time matters. A delayed chemotherapy cycle, a postponed radiotherapy session, an unavailable diagnostic investigation or an interrupted supply of essential medication can have serious consequences for patients,” she said.
Dr Kiarie appealed to the Ministry of Health and SHA to urgently address the operational challenges, streamline approval procedures, improve communication with healthcare providers and ensure patients receive the benefits to which they are entitled.
“We must ensure that the promise of expanded financial protection is not undermined by administrative barriers. Our collective measure of success should not simply be how much money is allocated to cancer care, but how many patients receive timely, appropriate and uninterrupted treatment,” she added.
Meanwhile, Clinical Radiation Oncologist at Kenyatta National Hospital and founder of Texas Cancer Centre, Dr Catherine Nyongesa, welcomed the government’s efforts to streamline cancer treatment, describing digitisation and standardisation as important steps towards improving patient care.
“They are trying to digitise and also have uniformity on how doctors prescribe medication and also improve on quality of the care so that there is some standard. The patient will be the main focus. This patient has a right to be treated anywhere and the records of the patient moves with the patient wherever they go,” said Dr Nyongesa.
by Sadik Hassan
